Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms

Patients with lymphoid malignancies have impaired humoral immunity caused by the disease itself and its treatment, placing them at risk for severe coronavirus disease-19 (COVID-19) and reduced response to vaccination. However, data for COVID-19 vaccine responses in patients with mature T cell and NK...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Mirei, Mori, Akio, Onozawa, Masahiro, Tsukamoto, Shihori, Senjo, Hajime, Ishio, Takashi, Yokoyama, Emi, Kanaya, Minoru, Izumiyama, Koh, Saito, Makoto, Muraki, Haruna, Morioka, Masanobu, Teshima, Takanori, Kondo, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978274/
https://www.ncbi.nlm.nih.gov/pubmed/36862167
http://dx.doi.org/10.1007/s00277-023-05142-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978274/
https://www.ncbi.nlm.nih.gov/pubmed/36862167
http://dx.doi.org/10.1007/s00277-023-05142-4

Ejemplares similares